Your browser doesn't support javascript.
loading
Systematic evidence review and meta-analysis of outcomes associated with cancer genetic counseling.
Culver, Julie O; Bertsch, Nicole L; Kurz, Raluca N; Cheng, Linda L; Pritzlaff, Mary; Rao, Smita K; Stasi, Shannon M; Stave, Christopher D; Sharaf, Ravi N.
Afiliação
  • Culver JO; USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA. Electronic address: jculver@med.usc.edu.
  • Bertsch NL; The Community Health Clinic, Topeka, IN.
  • Kurz RN; Charles R. Drew University of Medicine and Science, Los Angeles, CA.
  • Cheng LL; Quest Diagnostics Nichols Institute, San Juan Capistrano, CA.
  • Pritzlaff M; Ambry Genetics, Aliso Viejo, CA.
  • Rao SK; GeneXsure LLC, Nashville, TN.
  • Stasi SM; Seattle Children's Hospital, Seattle, WA.
  • Stave CD; Stanford University School of Medicine, Stanford, CA.
  • Sharaf RN; Division of Gastroenterology, Department of Medicine and Division of Epidemiology, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY.
Genet Med ; 26(1): 100980, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37688462
ABSTRACT

PURPOSE:

Genetic counseling (GC) is standard of care in genetic cancer risk assessment (GCRA). A rigorous assessment of the data reported from published studies is crucial to ensure the evidence-based implementation of GC.

METHODS:

We conducted a systematic review and meta-analysis of 17 patient-reported and health-services-related outcomes associated with pre- and post-test GC in GCRA in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology.

RESULTS:

Twenty-five of 5393 screened articles met inclusion criteria. No articles reporting post-test GC outcomes met inclusion criteria. For patient-reported outcomes, pre-test GC significantly decreased worry, increased knowledge, and decreased perceived risk but did not significantly affect patient anxiety, depression, decisional conflict, satisfaction, or intent to pursue genetic testing. For health-services outcomes, pre-test GC increased correct genetic test ordering, reduced inappropriate services, increased spousal support for genetic testing, and expedited care delivery but did not consistently improve cancer prevention behaviors nor lead to accurate risk assessment. The GRADE certainty in the evidence was very low or low. No included studies elucidated GC effect on mortality, cascade testing, cost-effectiveness, care coordination, shared decision making, or patient time burden.

CONCLUSION:

The true impact of GC on relevant outcomes is not known low quality or absent evidence. Although a meta-analysis found that pre-test GC had beneficial effects on knowledge, worry, and risk perception, the certainty of this evidence was low according to GRADE methodology. Further studies are needed to support the evidence-based application of GC in GCRA.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aconselhamento Genético / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aconselhamento Genético / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2024 Tipo de documento: Article